Kidney Function clinical trials

Explore recruiting kidney function clinical trials.

Recruiting kidney function studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Kidney Function trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

REVOLUTION; Randomized controlled trial comparing immediate versus extended release tacrolimus; reducing calcineurin inhibitor related toxicity in lung transplantation patients

Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

Mannitol versus normal saline in brain death donors and recipients of kidney allograft on delayed graft function (MAVERICK) – A double-blinded, placebo-controlled randomized clinical trial

Finland

Therapeutic use (Phase IV) EU CTIS Study details

A Phase 1 Open-label, Parallel-Group, Single-Dose Study to Evaluate the Pharmacokinetics and Safety of Obeldesivir in Participants With Normal Renal Function and Renal Impairment

Germany

Human Pharmacology (Phase I)- Other EU CTIS Study details

Comparative Study on the Mode of Action of Vicadrostat and Spironolactone on Protein Profiles and Renal Hemodynamic Effects in Patients with Heart Failure or Cardiovascular Disease and Chronic Kidney Disease (COMPARE-VS)

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 3 open-label, controlled, randomised, multi-centre trial comparing imlifidase and standard-of-care with standard-of-care alone in the treatment of severe anti-GBM antibody disease (Goodpasture disease)

Spain, Czechia, Germany, France, Italy, Sweden +6 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A randomized controlled open-label multicenter study to assess the efficacy of TCZ in treatment of late/chronic active antibody-mediated rejection in kidney transplant recipients

Sweden, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Kidney Function trials by city

Kidney Function in Toronto Kidney Function in Vancouver Kidney Function in Montreal Kidney Function in Calgary Kidney Function in Edmonton Kidney Function in Ottawa Kidney Function in Winnipeg Kidney Function in Quebec City Kidney Function in Hamilton Kidney Function in Kitchener Kidney Function in London Kidney Function in Halifax Kidney Function in New York Kidney Function in Los Angeles Kidney Function in Chicago Kidney Function in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease